Colorectal cancer in patients under 50 possesses distinct genetic and cellular signatures that may explain why the disease frequently presents with greater aggression in younger adults.
A study published in Nature Medicine indicates that these fundamental biological differences likely dictate how younger patients respond to standard therapeutic interventions.
Mapping the Tumor Microenvironment
Researchers from Massachusetts General Hospital, Brigham and Women’s Hospital, the Dana-Farber Cancer Institute, and the Broad Institute of MIT and Harvard analyzed more than 850,000 cells across 189 tumors to map gene expression.
In the most prevalent form of the disease, microsatellite-stable (MSS) colorectal cancer, tumors from younger patients showed a higher concentration of stromal cells. According to The Washington Post, these connective cells create a structural framework that can foster tumor growth and potentially insulate cancer cells from the reach of chemotherapy or the immune system.
Genetic Disparities in Younger Adults
Through computational examination of left-sided MSS tumors, scientists discovered 29 signaling pathways where cell-to-cell signaling was more intense in tumors from younger individuals, versus just seven pathways that showed heightened activity in tumors from older patients.
“The big question in the field has been, 'Why is this increasing?' and the second question is, 'Is this a different disease?'” said Prof. Ana Anderson, director of the Cancer Program at the Gene Lay Institute of Immunology and Inflammation at Brigham and Women's Hospital and one of the study's senior investigators.
Colorectal Cancer Incidence Rises Among Americans Under 50
The American Cancer Society reports a 2.9% annual increase in colorectal cancer incidence among Americans under 50 between 2013 and 2022. Younger patients are disproportionately diagnosed at advanced stages; according to the American Cancer Society, approximately 27% present with distant metastases, compared to 21% to 23% in older populations.
Dr. Yaron Rudnitzky, deputy director of the Surgical Division at Meir Medical Center and director of the Colorectal Surgery and Proctology Unit, said that younger patients often endure symptoms such as abdominal pain or bloody stools for a full year before receiving a formal diagnosis.
“People in their 40s don’t think they can have cancer,” Rudnitzky said.
“Very often they have been walking around for a year with abdominal pain, bloody stools or weight loss,” Rudnitzky said.
Early-Onset Colorectal Cancer Links to Accelerated Biological Aging
A separate review in the journal Trends in Cancer links early-onset colorectal cancer to accelerated biological aging. Researchers at the IMDEA Nutrición Institute noted evidence of DNA damage and immune system dysregulation, suggesting the disease may stem from systemic processes extending beyond the colon.
While these findings offer new clarity, the connection between these biological traits and clinical treatment resistance remains a hypothesis. Further research is necessary to determine if these molecular patterns can function as targets for personalized medicine.
“The study doesn’t tell us why this is happening in younger people,” Rudnitzky said.
For now, clinicians maintain that persistent symptoms, including unexplained weight loss or rectal bleeding, require evaluation regardless of the patient’s age.
Worth a look